Investigating a new target for treating obesity-related insulin resistance
TP-R: a novel mediator of obesity-linked insulin resistance in humans
This study is looking at how a specific molecule and its receptor affect weight gain and how our bodies use insulin, with the goal of finding new ways to help people with obesity improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Omaha VA Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11073079 on NIH RePORTER |
What this research studies
This research explores the role of thromboxane A2 (TXA2) and its receptor (TP-R) in obesity and insulin resistance. It aims to understand how TP-R influences metabolic pathways, particularly in adipose tissue, which is crucial for fat storage and amino acid metabolism. By studying the effects of TP-R on inflammation and insulin sensitivity, the research seeks to identify potential therapeutic targets for improving metabolic health in individuals with obesity. The study will utilize clinical, biochemical, and molecular methods to gather comprehensive data on these mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults struggling with obesity and insulin resistance, particularly those with elevated levels of branched chain amino acids.
Not a fit: Patients who are not affected by obesity or insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for obesity-related insulin resistance, improving metabolic health for many patients.
How similar studies have performed: While the specific approach of targeting TP-R is novel, related research has shown promise in understanding the metabolic roles of adipose tissue in insulin resistance.
Where this research is happening
Omaha, United States
- Omaha VA Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Viswanathan, Saraswathi — Omaha VA Medical Center
- Study coordinator: Viswanathan, Saraswathi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.